Ivan Kairatov is a Biopharma expert, with deep knowledge in tech and innovation in the industry and experience in research and development. Today, we will discuss the intricacies of protein kinase research, the role of AI in predicting interactions, and the development of KinasePred. Can you
Parkinson's disease, a devastating neurodegenerative disorder, is characterized by the relentless loss of dopaminergic neurons, which leads to significant motor dysfunction and a decline in overall quality of life. Central to the pathology of PD are aggregates of alpha-synuclein protein and
The University of Manchester recently celebrated a significant milestone with the launch of the British Heart Foundation (BHF) Manchester Center of Research Excellence. Supported by a substantial £4 million grant from the BHF, this new center is set to advance world-class cardiovascular research
Chloe Botaine engages Ivan Kairatov, a Biopharma expert with significant knowledge of tech and innovation within the industry, for a detailed discussion on the new AI-based system LILAC (Learning-based Inference of Longitudinal imAge Changes). Topics covered include the system's workings, its
Emalex Biosciences recently shared tremendous news regarding their latest breakthrough in the treatment of Tourette syndrome. The company announced promising topline results from its Phase 3 registrational study of ecopipam, a novel dopamine-1 receptor antagonist. This milestone could position
The recent FDA Fast Track designation for BioRestorative Therapies' BRTX-100 program marks a significant milestone in the treatment of chronic lumbar disc disease (cLDD). Given the debilitating nature of cLDD and its prevalence among middle-aged Americans, this development has sparked considerable
